{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:43:55Z","timestamp":1774435435591,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K11006"],"award-info":[{"award-number":["18K11006"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K11115"],"award-info":[{"award-number":["18K11115"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bbadis.2021.166215","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T02:12:14Z","timestamp":1626142334000},"page":"166215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Regulation of the expression of cholesterol transporters by lipid-lowering drugs ezetimibe and pemafibrate in rat liver and intestine"],"prefix":"10.1016","volume":"1867","author":[{"given":"Yuji","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Kamisako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2021.166215_bb0005","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJM199006143222403","article-title":"Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease","volume":"322","author":"Pekkanen","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2021.166215_bb0010","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM198904063201405","article-title":"Serum cholesterol levels and six year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial","volume":"320","author":"Iso","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2021.166215_bb0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1185\/030079905X382004","article-title":"LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia","volume":"21","author":"Brohet","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bbadis.2021.166215_bb0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jjcc.2013.06.018","article-title":"Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size","volume":"63","author":"Tani","year":"2014","journal-title":"J. Cardiol."},{"key":"10.1016\/j.bbadis.2021.166215_bb0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.5551\/jat.44412","article-title":"Efficacy and safety of pemafibrate versus fenofibrate in patients with high triglyceride and low HDL cholesterol levels: a multicenter, placebo-controlled, double-blind, randomized trial","volume":"25","author":"Arai","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.bbadis.2021.166215_bb0030","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1161\/CIRCULATIONAHA.104.523563","article-title":"Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2021.166215_bb0035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-pick C1 like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2021.166215_bb0040","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.1074\/jbc.M508868200","article-title":"Accelerated lipid absorption in mice overexpressing intestinal SR-BI","volume":"281","author":"Bietrix","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166215_bb0045","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/gast.2001.23250","article-title":"ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism","volume":"120","author":"Drobnik","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2021.166215_bb0050","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/j.gastro.2007.06.019","article-title":"Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice","volume":"133","author":"Velde","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2021.166215_bb0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cmet.2010.05.011","article-title":"Biliary sterol secretion is not required for macrophage reverse cholesterol transport","volume":"12","author":"Temel","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2021.166215_bb0060","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cmet.2016.10.001","article-title":"Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion","volume":"24","author":"Jakulj","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2021.166215_bb0065","doi-asserted-by":"crossref","first-page":"19211","DOI":"10.1074\/jbc.M109.014860","article-title":"Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol","volume":"284","author":"Veen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166215_bb0070","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1053\/j.gastro.2016.12.037","article-title":"Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice","volume":"152","author":"Boer","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2021.166215_bb0075","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1194\/jlr.M067488","article-title":"Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice","volume":"57","author":"Schonewille","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2021.166215_bb0080","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/ATVBAHA.112.300263","article-title":"Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1","volume":"33","author":"May","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2021.166215_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152207","article-title":"Ezetimibe promotes brush border membrane-to-lumen cholesterol efflux in the small intestine","volume":"11","author":"Nakano","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2021.166215_bb0090","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbalip.2014.05.009","article-title":"Ezetimibe enhances macrophage reverse cholesterol transport in hamsters: contribution of hepato-biliary pathway","volume":"1841","author":"Uto-Kondo","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2021.166215_bb0095","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1194\/jlr.M800579-JLR200","article-title":"Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux","volume":"50","author":"Vrins","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2021.166215_bb0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11010-020-03826-3","article-title":"NPC1L1 and ABCG5\/8 induction explain synergistic fecal cholesterol excretion in ob\/ob mice co-treated with PPAR-\u03b1 and LXR agonists, Mol","volume":"473","author":"Srivastava","year":"2020","journal-title":"Cell Biochem."},{"key":"10.1016\/j.bbadis.2021.166215_bb0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2008.01.045","article-title":"Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice","volume":"584","author":"Zheng","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2021.166215_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2016.03.003","article-title":"The novel selective PPAR\u03b1 modulator (SPPARM\u03b1) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis","volume":"249","author":"Hennuyer","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2021.166215_bb0115","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3390\/ijms19072148","article-title":"The peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) agonist pemafibrate protects against diet-induced obesity in mice","volume":"19","author":"Araki","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2021.166215_bb0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166215_bb0125","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1053\/j.gastro.2006.02.012","article-title":"Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity","volume":"130","author":"Hubbard","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2021.166215_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/jpet.120.265660","article-title":"Ezetimibe markedly reduces hepatic triglycerides and cholesterol in rats fed on fish oil by increasing the expression of cholesterol efflux transporters","volume":"374","author":"Tanaka","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2021.166215_bb0135","first-page":"16529","article-title":"FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis, Sci","volume":"8","author":"Golen","year":"2018","journal-title":"Rep."},{"key":"10.1016\/j.bbadis.2021.166215_bb0140","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1046\/j.1523-1755.2002.00341.x","article-title":"Monitoring changes in gene expression in renal ischemia-reperfusion in the rat","volume":"61","author":"Yoshida","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2021.166215_bb0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000252350","article-title":"Dietary phytosterols and phytostanols alter the expression of sterol-regulatory genes in SHRSP and WKY inbred rats","volume":"55","author":"Chen","year":"2009","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.bbadis.2021.166215_bb0150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/jpet.117.246165","article-title":"Reduction in secretion of very low density lipoprotein-triacylglycerol by a matrix metalloproteinase inhibitor in a rat model of diet-induced hypertriglyceridemia","volume":"366","author":"Kawashima","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2021.166215_bb0155","first-page":"1691","article-title":"Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in bile duct-ligated rats","volume":"8","author":"Chai","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bbadis.2021.166215_bb0160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1476-511X-12-118","article-title":"Acute stress show great influences on liver function and the expression of hepatic genes associated with lipid metabolism in rats","volume":"12","author":"Gao","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbadis.2021.166215_bb0165","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2337\/diabetes.50.6.1330","article-title":"Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters","volume":"50","author":"Heek","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2021.166215_bb0170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/hepr.12092","article-title":"Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in Fatty Liver Shionogi mouse","volume":"44","author":"Wang","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbadis.2021.166215_bb0175","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3892\/mmr.2014.2623","article-title":"Ezetimibe prevents the development of non-alcoholic fatty liver disease induced by high-fat diet in C57BL\/6J mice","volume":"10","author":"Wang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2021.166215_bb0180","doi-asserted-by":"crossref","first-page":"754","DOI":"10.5551\/jat.28720","article-title":"Transcriptome analysis of K-877 (a novel selective PPAR\u03b1 modulator (SPPARM\u03b1))-regulated genes in primary human hepatocytes and the mouse liver","volume":"22","author":"Raza-Iqbal","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.bbadis.2021.166215_bb0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/ijms21010361","article-title":"Elucidation of molecular mechanism of a selective PPAR\u03b1 modulator, pemafibrate, through combinational approaches of X-ray crystallography, thermodynamic analysis, and first-principle calculations","volume":"21","author":"Kawasaki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2021.166215_bb0190","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2013.08.006","article-title":"Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans","volume":"230","author":"Davidson","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2021.166215_bb0195","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/ATVBAHA.117.309119","article-title":"Ezetimibe increases endogenous cholesterol excretion in humans","volume":"37","author":"Lin","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2021.166215_bb0200","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.metabol.2014.06.014","article-title":"Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment","volume":"63","author":"Altemus","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2021.166215_bb0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1386-6346(02)00248-6","article-title":"Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat. Disappearance of abcg5 and abcg8 mRNA after bile duct ligation","volume":"25","author":"Kamisako","year":"2003","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbadis.2021.166215_bb0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00795-017-0166-7","article-title":"Increased hepatic ABCA1 transporter is associated with hypercholesterolemia in a cholestatic rat model and primary biliary cholangitis patients","volume":"50","author":"Takeyama","year":"2017","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.bbadis.2021.166215_bb0215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1042\/bj3560317","article-title":"Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine","volume":"356","author":"Voshol","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2021.166215_bb0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-1746.2006.04365.x","article-title":"Effect of bile duct obstruction on the expression of intestinal mRNA related to cholesterol and bile acid metabolism in the rat","volume":"22","author":"Kamisako","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2021.166215_bb0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02533403","article-title":"Diet and sterol biohydrogenation in the rat: occurrence of epicoprostanol","volume":"13","author":"Sulpice","year":"1978","journal-title":"Lipids"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443921001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443921001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:04:11Z","timestamp":1760418251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443921001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0925443921001484"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2021.166215","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of the expression of cholesterol transporters by lipid-lowering drugs ezetimibe and pemafibrate in rat liver and intestine","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2021.166215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166215"}}